Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dizal Pharma
Pharma
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Kelun and Hansoh reported positive phase 3s for their Big Pharma-partnered ADCs. AZ buys an EGFR lung cancer med from its spinout Dizal. And more.
Angus Liu
Jul 17, 2026 9:38am
AstraZeneca buys lung cancer drug Zegfrovy from Dizal for $1.5B
Jul 14, 2026 9:57am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
Dizal takes on J&J with first-line win in EGFR lung cancer type
May 29, 2026 8:00am
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
Dizal's Zegfrovy adds more pressure to J&J's Rybrevant
Mar 23, 2026 10:25am
